TY - JOUR
T1 - Molecular mechanism of EGFR signaling evoked by environmental pollutant 1,2-naphthoquinone
AU - Tsuchida, Tomoki
AU - Uehara, Takashi
N1 - Publisher Copyright:
© 2022, Japanese Pharmacological Society. All rights reserved.
PY - 2022
Y1 - 2022
N2 - The epidermal growth factor receptor (EGFR) is the most extensively examined receptor tyrosine kinase. Several EGFR mutations and modifications have been shown to induce self-activation, which plays a central role in carcinogenesis. Recently, environmental chemicals such as PM2.5 can also activate EGFR and become risk factors for cancer. Although, the detailed mechanism remains unknown. In this study, we focused on 1,2-naphthoquinone (1,2-NQ) which is a secondary metabolite of naphthalene. Humans are exposed to 1,2-NQ through the combustion of fossil and diesel fuel and from tobacco smoke and PM2.5. Here, we demonstrate that 1,2-NQ is a novel EGFR-specific activator. We found that 1,2-NQ forms a covalent bond called N-arylation with EGFR Lys80 which is in the extracellular domain by LC-MS/MS. This modification activates the EGFR-Akt signaling pathway, which inhibits serum deprivation-induced apoptosis in A549 cells. Our study reveals an original mode of EGFR activation via covalent binding. We propose the correlation between EGFR activation without ligands and environmental pollutant-associated diseases such as cancer.
AB - The epidermal growth factor receptor (EGFR) is the most extensively examined receptor tyrosine kinase. Several EGFR mutations and modifications have been shown to induce self-activation, which plays a central role in carcinogenesis. Recently, environmental chemicals such as PM2.5 can also activate EGFR and become risk factors for cancer. Although, the detailed mechanism remains unknown. In this study, we focused on 1,2-naphthoquinone (1,2-NQ) which is a secondary metabolite of naphthalene. Humans are exposed to 1,2-NQ through the combustion of fossil and diesel fuel and from tobacco smoke and PM2.5. Here, we demonstrate that 1,2-NQ is a novel EGFR-specific activator. We found that 1,2-NQ forms a covalent bond called N-arylation with EGFR Lys80 which is in the extracellular domain by LC-MS/MS. This modification activates the EGFR-Akt signaling pathway, which inhibits serum deprivation-induced apoptosis in A549 cells. Our study reveals an original mode of EGFR activation via covalent binding. We propose the correlation between EGFR activation without ligands and environmental pollutant-associated diseases such as cancer.
UR - http://www.scopus.com/inward/record.url?scp=85137057907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137057907&partnerID=8YFLogxK
U2 - 10.1254/fpj.22043
DO - 10.1254/fpj.22043
M3 - Article
C2 - 36047152
AN - SCOPUS:85137057907
SN - 0015-5691
VL - 157
SP - 352
EP - 355
JO - Folia Pharmacologica Japonica
JF - Folia Pharmacologica Japonica
IS - 5
ER -